glp 1 for people without diabetes GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 There's a lot of misinformation
Description
A critical analysis of the clinical use of incretin-based therapies: are the GLP-1 therapies safe
13, 2022, article 951186
This doesnt change your level of contraceptive protection, but your healthcare provider may want to monitor your blood sugar more closely and adjust your medication if needed (7,19)
Berberine and neurodegeneration: a review of literature
Early data suggests that while retatrutide produces more dramatic weight loss, the gastrointestinal side effect patterns may differ from those seen with semaglutide alone
